ArticleBMC cancer2018

Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort.

Danja Sarink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.